Table 7.
Sub-criteria
of Tangible assets |
Relative weight of Main criteria matrix (%)
In generic pharmaceutical industry |
CR |
Relative weight of Main criteria matrix (%)
In bio-generic pharmaceutical industry |
CR |
---|---|---|---|---|
Production facility | 0.262 | .030 | 0.240 | .007 |
Testing facility | 0.166 | 0.250 | ||
personnel | 0.139 | 0.202 | ||
R&D investment | 0.434 | 0.308 |